Evidence map›Paper›PMID 40183885›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025

Treatment summaries for head and neck cancer survivors: a pilot study to improving patient recall and survivorship care plans.

Shreyas G Krishnapura, Aaron X Lee, Tatsuki Koyama, James L Netterville, Kyle Mannion, Alexander J Langerman, Robert Sinard, Sarah L Rohde, Michael C Topf

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shreyas G KrishnapuraSchool of Medicine, Vanderbilt University, Nashville, TN, USA. krishss@ucmail.uc.edu.
Aaron X LeeDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
Tatsuki KoyamaDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
James L NettervilleDepartment of Otolaryngology - Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
Kyle MannionDepartment of Otolaryngology - Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
Alexander J LangermanDepartment of Otolaryngology - Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
Robert SinardDepartment of Otolaryngology - Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
Sarah L RohdeDepartment of Otolaryngology - Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
Michael C TopfDepartment of Otolaryngology - Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.

Funding

Vanderbilt Clinical Oncology Research Career Development ProgramK12CA090625 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Debra L. Friedman, Paula Jill Hurley · 2001 to 2026
$16.9M
Augmented Reality to Guide Head and Neck Cancer SurgeryK08CA293255 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Michael Topf · 2024 to 2026
$645k
NCI NIH HHS K08 CA293255NCI NIH HHS K12 CA090625
6 · The paper itself

Abstract

backgroundThe treatment summary (TS) remains underused in head and neck cancer (HNC). We determine if receiving a personalized TS following a definitive HNC treatment improves patient recall of treatment details.

methodA history questionnaire was administered to assess patient accuracy in reporting diagnosis and treatment-related details at baseline (pre-TS) and 1-month follow-up (post-TS). Statistical significance of accuracy changes was assessed using McNemar's chi squared test.

resultsOne hundred participants were enrolled between January and December 2022. Ninety-one completed all surveys. Significant improvement in correct responses was noted for questions regarding cancer diagnosis type (94.5% post-TS, 78.0% pre-TS, p = 0.002), cancer diagnosis date (75.8% post-TS, 40.7% pre-TS, p < 0.001), T-stage (82.4% post-TS, 28.6% pre-TS, p < 0.001), and lymph node status (91.2% post-TS, 63.7% pre-TS, p < 0.001).

conclusionTS may improve HNC survivors' recall about their diagnosis and treatment in the short term. Patients view TS as beneficial to their survivorship care plans. IMPLICATIONS FOR CANCER SURVIVORS: TS in survivorship care plans are understudied in HNC patients. This investigation will serve as a meaningful contribution to the literature, promote additional investigation, and encourage improvement of informative resources available to HNC survivors.

Indexed as

Cancer SurvivorsHead and Neck NeoplasmsMental RecallPatient Care PlanningSurvivorshipAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedPilot ProjectsSurveys and QuestionnairesCancer survivalHead and neck surgeryOtolaryngologyPatient recallPatient safetyQuality improvementSurvivorship care

Identifiers

PMID40183885
PMCPMC11971132

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.